The Utility of Serum Receptor-Binding Cancer Antigen Expressed on Siso Cells in Gastrointestinal Tract Cancers | Zendy

Şahin Çoban | Zendy; Hasan Özkan | Zendy; Seyfettin Köklü | Zendy; Osman Yüksel | Zendy; Muhammed Cem Koçkar | Zendy; Tarık Akar | Zendy; Necati Örmecı | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Utility of Serum Receptor-Binding Cancer Antigen Expressed on Siso Cells in Gastrointestinal Tract Cancers

Author(s) -

Şahin Çoban,

Hasan Özkan,

Seyfettin Köklü,

Osman Yüksel,

Muhammed Cem Koçkar,

Tarık Akar,

Necati Örmecı

Publication year - 2006

Publication title -

canadian journal of gastroenterology

Language(s) - English

Resource type - Journals

eISSN - 1916-7237

pISSN - 0835-7900

DOI - 10.1155/2006/276247

Subject(s) - carcinoembryonic antigen , medicine , colorectal cancer , esophagus , cancer , antigen , lymph node , gastrointestinal tract , malignancy , gastrointestinal cancer , cancer antigen , pathology , oncofetal antigen , immunohistochemistry , gastroenterology , oncology , immunology , immunotherapy , tumor associated antigen

Receptor-binding cancer antigen expressed on SiSo cells (RCAS1) is a novel tumour marker that has been described in various kinds of cancer. The majority of observations include immunohistochemical studies; however, there are not enough data about the utility of this antigen as a serum tumour marker and its tumour specificity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research